Tenderwize
Retour à la recherche

Open-house biologics rebate agreement for Teriparatide

Techniker Krankenkasse·Hamburg, Germany·Deadline Apr 29, 2028 · 612 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-06 - Teriparatid

61/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

61 / 100

Complexité

56 / 100

Facteurs de risque

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Conclusion of rebate agreements for the active substance Teriparatid.
  • Supply arrangement for pharmaceutical products under an open-house model.
Afficher le résumé complet

Open-house supply arrangement for pharmaceutical products (Teriparatid) led by Techniker Krankenkasse with HEK and hkk as participating buyers. The procedure is non-exclusive, with no individual negotiations and uniform conditions for all suitable pharmaceutical undertakings. The contract term is up to 24 months from 01.05.2026 and ends no later than 30.04.2028. Documents are available online, but only the XML/tender text was provided here, so procurement documents were not fully analyzed.

Risques

The structured data gives a deadline of 2028-04-29 21:59:59 UTC, while the XML text also mentions 2028-04-30 as an end...

The notice says offers/contracts cannot be submitted via the portal; submission must be by email with qualified electro...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The bidder must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the offered medicinal products.
  • The bidder must have its seat in the AMG territory, another EU Member State, or an EEA state.
  • A valid marketing authorization for the contract medicinal product(s) is required, or another legal basis to place the product on the market in its own name.

Critères d'attribution

Lot 1

No explicit award criteria provided; open-house uniform conditions only.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open-house biologics rebate agreement for Teriparatide

Supply contract for Teriparatid under an open-house procedure. Scope is nationwide in Germany. The arrangement is non-exclusive and open to all eligible pharmaceutical undertakings during the contract period.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Apr 2026 - Apr 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No explicit award criteria provided; open-house uniform conditions only.

Date limite

Deadline Apr 29, 2028

Détails de la procédure

Date de publication
15 Mar 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
179543-2026

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3